These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20950071)

  • 1. Health-state utility values in breast cancer.
    Peasgood T; Ward SE; Brazier J
    Expert Rev Pharmacoecon Outcomes Res; 2010 Oct; 10(5):553-66. PubMed ID: 20950071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tamoxifen for breast cancer risk reduction: impact of alternative approaches to quality-of-life adjustment on cost-effectiveness analysis.
    Melnikow J; Birch S; Slee C; McCarthy TJ; Helms LJ; Kuppermann M
    Med Care; 2008 Sep; 46(9):946-53. PubMed ID: 18725849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-based utilities for bipolar disorder-related health states.
    Revicki DA; Hanlon J; Martin S; Gyulai L; Nassir Ghaemi S; Lynch F; Mannix S; Kleinman L
    J Affect Disord; 2005 Aug; 87(2-3):203-10. PubMed ID: 16005983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health-related quality of life, satisfaction, and economic outcome measures in studies of prostate cancer screening and treatment, 1990-2000.
    McNaughton-Collins M; Walker-Corkery E; Barry MJ
    J Natl Cancer Inst Monogr; 2004; (33):78-101. PubMed ID: 15504921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health state utility values in locally advanced and metastatic breast cancer by treatment line: a systematic review.
    Paracha N; Thuresson PO; Moreno SG; MacGilchrist KS
    Expert Rev Pharmacoecon Outcomes Res; 2016 Oct; 16(5):549-559. PubMed ID: 27574879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost utility and budget impact of third-generation aromatase inhibitors for advanced breast cancer: a literature-based model analysis of costs in the Italian National Health Service.
    Marchetti M; Caruggi M; Colombo G
    Clin Ther; 2004 Sep; 26(9):1546-61. PubMed ID: 15531017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The validity and responsiveness of generic utility measures in rheumatoid arthritis: a review.
    Harrison MJ; Davies LM; Bansback NJ; Ingram M; Anis AH; Symmons DP
    J Rheumatol; 2008 Apr; 35(4):592-602. PubMed ID: 18278841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of extended adjuvant letrozole therapy after 5 years of adjuvant tamoxifen therapy in postmenopausal women with early-stage breast cancer.
    Delea TE; Karnon J; Smith RE; Johnston SR; Brandman J; Sung JC; Gross PE
    Am J Manag Care; 2006 Jul; 12(7):374-86. PubMed ID: 16834524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index.
    Dan AA; Kallman JB; Srivastava R; Younoszai Z; Kim A; Younossi ZM
    Liver Transpl; 2008 Mar; 14(3):321-6. PubMed ID: 18306356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preferences for health outcomes and cost-utility analysis.
    Torrance GW
    Am J Manag Care; 1997 May; 3 Suppl():S8-20. PubMed ID: 10180342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility Values for Adults with Unipolar Depression: Systematic Review and Meta-Analysis.
    Mohiuddin S; Payne K
    Med Decis Making; 2014 Jul; 34(5):666-85. PubMed ID: 24695961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility and work productivity data for economic evaluation of breast cancer therapies in the Netherlands and Sweden.
    Frederix GW; Quadri N; Hövels AM; van de Wetering FT; Tamminga H; Schellens JH; Lloyd AJ
    Clin Ther; 2013 Apr; 35(4):e1-7. PubMed ID: 23541706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review and Meta-analysis of Childhood Health Utilities.
    Kwon J; Kim SW; Ungar WJ; Tsiplova K; Madan J; Petrou S
    Med Decis Making; 2018 Apr; 38(3):277-305. PubMed ID: 28990449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health state utilities for metastatic breast cancer in Taiwan.
    Chou TC; Chiang SC; Ko Y
    Breast; 2020 Jun; 51():57-64. PubMed ID: 32213442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping utilities from cancer-specific health-related quality of life instruments: a review of the literature.
    McTaggart-Cowan H; Teckle P; Peacock S
    Expert Rev Pharmacoecon Outcomes Res; 2013 Dec; 13(6):753-65. PubMed ID: 24219051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review and meta-analysis of utility values for lung cancer.
    Sturza J
    Med Decis Making; 2010; 30(6):685-93. PubMed ID: 20448248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review and meta-analysis of prostate cancer utilities.
    Bremner KE; Chong CA; Tomlinson G; Alibhai SM; Krahn MD
    Med Decis Making; 2007; 27(3):288-98. PubMed ID: 17502448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Meta-Regression Analysis of Utility Weights for Breast Cancer: The Power of Patients' Experience.
    Gong JR; Han J; Lee D; Bae S
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33333997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Review and Meta-analysis of Colorectal Cancer Utilities.
    Djalalov S; Rabeneck L; Tomlinson G; Bremner KE; Hilsden R; Hoch JS
    Med Decis Making; 2014 Aug; 34(6):809-18. PubMed ID: 24903121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.